Characterization of an In Vivo Neutralizing Anti-Vaccinia Virus D8 Single-Chain Fragment Variable (scFv) from a Human Anti-Vaccinia Virus-Specific Recombinant Library
A panel of potent neutralizing antibodies are protective against orthopoxvirus (OPXV) infections. For the development of OPXV-specific recombinant human single-chain antibodies (scFvs), the IgG repertoire of four vaccinated donors was amplified from peripheral B-lymphocytes. The resulting library co...
Guardado en:
Autores principales: | Ulrike S. Diesterbeck, Henrike P. Ahsendorf, André Frenzel, Ahmad Reza Sharifi, Thomas Schirrmann, Claus-Peter Czerny |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/46ac0221921e4932ad936734ce702782 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A novel variable antibody fragment dimerized by the dHLX peptide with enhanced affinity against amantadine compared to its corresponding scFv antibody
por: Sanlei Xie, et al.
Publicado: (2018) -
A comprehensive comparison between camelid nanobodies and single chain variable fragments
por: Yasaman Asaadi, et al.
Publicado: (2021) -
Anti-<i>Staphylococcus aureus</i> Single-Chain Fragment Variables Play a Protective Anti-Inflammatory Role In Vitro and In Vivo
por: Lei Zhang, et al.
Publicado: (2021) -
Route-coupled pathogenicity and immunogenicity of vaccinia virus variant inoculated mice
por: S. N. Shchelkunov, et al.
Publicado: (2021) -
Engineered Fully Human Single-Chain Monoclonal Antibodies to PIM2 Kinase
por: Kanasap Kaewchim, et al.
Publicado: (2021)